Stem Cells as a Source of Pancreatic Cells for Production of 3D Bioprinted Bionic Pancreas in the Treatment of Type 1 Diabetes

Stem Cells as a Source of Pancreatic Cells for Production of 3D Bioprinted Bionic Pancreas in the Treatment of Type 1 Diabetes

Type 1 diabetes (T1D) is the third most common autoimmune disease which develops due to genetic and environmental risk factors. Often, intensive insulin therapy is insufficient, and patients require a pancreas or pancreatic islets transplant. However, both solutions are associated with many possible...

Full description

Bibliographic Details
Main Authors: Michał Wszoła, Daria Nitarska, Piotr Cywoniuk, Magdalena Gomółka, Marta Klak
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cells
Subjects:
stem cells
pancreas
3D bioprinting
diabetes
CRISPR/Cas9
alpha cells
Online Access:https://www.mdpi.com/2073-4409/10/6/1544

Similar Items

Similar Items